Julie  Winkler net worth and biography

Julie Winkler Biography and Net Worth

Insider of CME Group

Julie Winkler is the chief commercial officer for CME Group, a role she has held since 2015. In her position, she leads sales, product marketing, research and product development, data analytics and digitization, as well as the company’s innovation lab. 

Prior to taking on the chief commercial officer role, Winkler served as senior managing director of research, product development and index services and as managing director of research and product development. 

Previously, she joined the Chicago Board of Trade as a staff investigator in the office of investigations and audits, and in 1998, she joined the business development area as an economist in the research and strategic analysis group. She was promoted to managing director of business development in 2004. She also served as VP of business development.

She currently serves on the boards of S&P Dow Jones Indices LLC and Valparaiso University. She is also a Revenue 50 member within the World 50 network.

Winkler earned her bachelor’s degree in business administration and finance from Valparaiso University and her M.B.A. from Loyola University. 

What is Julie Winkler's net worth?

The estimated net worth of Julie Winkler is at least $6.05 million as of August 10th, 2023. Ms. Winkler owns 25,373 shares of CME Group stock worth more than $6,052,222 as of December 21st. This net worth approximation does not reflect any other investments that Ms. Winkler may own. Learn More about Julie Winkler's net worth.

How do I contact Julie Winkler?

The corporate mailing address for Ms. Winkler and other CME Group executives is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. CME Group can also be reached via phone at (312) 930-1000 and via email at [email protected]. Learn More on Julie Winkler's contact information.

Has Julie Winkler been buying or selling shares of CME Group?

Julie Winkler has not been actively trading shares of CME Group during the last quarter. Most recently, Julie Winkler sold 6,262 shares of the business's stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $207.00, for a transaction totalling $1,296,234.00. Following the completion of the sale, the insider now directly owns 25,373 shares of the company's stock, valued at $5,252,211. Learn More on Julie Winkler's trading history.

Who are CME Group's active insiders?

CME Group's insider roster includes Timothy Bitsberger (Director), Charles Carey (Director), Elizabeth Cook (Director), Kathleen Cronin (Insider), Sunil Cutinho (Insider), Terrence Duffy (Chairman & CEO), Bryan Durkin (Director), Lynne Fitzpatrick (Senior Managing Director & Deputy CFO), Martin Gepsman (Director), Phupinder Gill (CEO), Daniel Glickman (Director), Julie Holzrichter (COO), Kevin Kometer (Insider), Timothy McCourt (Insider), Hilda Piell (Insider), John Pietrowicz (CFO), Derek Sammann (Insider), Terry Savage (Director), Terry Savage (Director), William Shepard (Director), Howard Siegel (Director), Dennis Suskind (Director), Jack Tobin (CAO), Sean Tully (Insider), Ken Vroman (Insider), and Julie Winkler (Insider). Learn More on CME Group's active insiders.

Are insiders buying or selling shares of CME Group?

In the last year, CME Group insiders bought shares 5 times. They purchased a total of 109 shares worth more than $22,402.94. In the last year, insiders at the financial services provider sold shares 13 times. They sold a total of 69,946 shares worth more than $14,842,000.51. The most recent insider tranaction occured on November, 4th when Director Martin J Gepsman sold 400 shares worth more than $89,168.00. Insiders at CME Group own 0.3% of the company. Learn More about insider trades at CME Group.

Information on this page was last updated on 11/4/2024.

Julie Winkler Insider Trading History at CME Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2023Sell6,262$207.00$1,296,234.0025,373View SEC Filing Icon  
5/27/2021Sell3,500$217.00$759,500.0025,400View SEC Filing Icon  
12/14/2020Sell4,059$181.02$734,760.1824,921View SEC Filing Icon  
2/24/2020Sell5,620$210.97$1,185,651.4025,114View SEC Filing Icon  
11/16/2018Sell5,847$195.01$1,140,223.4724,255View SEC Filing Icon  
12/7/2017Sell2,457$150.41$369,557.3716,318View SEC Filing Icon  
6/12/2017Sell4,315$124.95$539,159.2519,670View SEC Filing Icon  
2/24/2017Sell5,888$122.53$721,456.6414,095View SEC Filing Icon  
See Full Table

Julie Winkler Buying and Selling Activity at CME Group

This chart shows Julie Winkler's buying and selling at CME Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CME Group Company Overview

CME Group logo
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $238.53
Low: $235.60
High: $240.31

50 Day Range

MA: $230.71
Low: $221.17
High: $246.02

2 Week Range

Now: $238.53
Low: $190.70
High: $249.02

Volume

3,172,049 shs

Average Volume

1,976,343 shs

Market Capitalization

$85.96 billion

P/E Ratio

25.08

Dividend Yield

1.95%

Beta

0.56